GFAP and Alzheimer disease: Other plasma biomarkers such as neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) are not specific to AD but reflect broader neurodegenerative processes, including neuroaxonal damage and neuroinflammation, respectively.